Imago BioSciences (NASDAQ:IMGO) Trading 8.1% Higher

Imago BioSciences Inc (NASDAQ:IMGO) shares traded up 8.1% on Thursday . The stock traded as high as $24.33 and last traded at $24.33. 939 shares were traded during trading, a decline of 100% from the average session volume of 222,141 shares. The stock had previously closed at $22.51.

IMGO has been the subject of a number of recent research reports. Cowen initiated coverage on shares of Imago BioSciences in a report on Tuesday, August 10th. They issued an “outperform” rating for the company. Guggenheim initiated coverage on shares of Imago BioSciences in a report on Tuesday, August 10th. They issued a “buy” rating and a $35.00 price objective for the company. Jefferies Financial Group initiated coverage on shares of Imago BioSciences in a report on Tuesday, August 10th. They issued a “buy” rating and a $30.00 price objective for the company. Finally, Stifel Nicolaus initiated coverage on shares of Imago BioSciences in a research report on Tuesday, August 10th. They set a “buy” rating and a $31.00 price objective for the company.

The company has a 50-day moving average of $22.76.

Imago BioSciences (NASDAQ:IMGO) last issued its quarterly earnings results on Wednesday, August 18th. The company reported ($8.13) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.33) by ($7.80). On average, research analysts anticipate that Imago BioSciences Inc will post -1.68 EPS for the current year.

About Imago BioSciences (NASDAQ:IMGO)

Imago BioSciences Inc is a clinical stage biopharmaceutical company. It involved in discovering new medicines for the treatment of myeloproliferative neoplasms. Imago BioSciences Inc is based in SOUTH SAN FRANCISCO, Calif.

Further Reading: Trading Strategy

Receive News & Ratings for Imago BioSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imago BioSciences and related companies with MarketBeat.com's FREE daily email newsletter.